Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
JTO Clinical and Research Reports|July 4, 2025
A Prospective Exploratory Study of Functional Immunity Assessed by Pretreatment Interferon Gamma Release Assay in Relation to Different Systemic Therapies in Patients With Advanced-Stage NSCLCHsu-Ching Huang, Han-Jhih Chang, Chi-Lu Chiang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Clinical characteristics and treatment outcomes of lung adenocarcinomas with discrepant EGFR mutation testing results derived from PCR-direct sequencing and real-time PCR-based assaysChao-Hua Chiu, Hsiang-Ling Ho, Chi-Lu Chiang, et al.
Oncotarget|February 14, 2018
Effect of postoperative systemic therapy on pulmonary adenocarcinoma with unexpected pleural spread detected during thoracotomy or thoracoscopyChi-Lu Chiang, Lei-Chi Wang, Hsiang-Ling Ho, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
The predictive value of the interferon-γ release assay for chemotherapy responses in patients with advanced non-small-cell lung cancerHsu-Ching Huang, Wei-Juin Su, Chi-Lu Chiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancerTeh-Ying Chou, Chao-Hua Chiu, Ling-Hui Li, et al.
Journal of Cancer Research and Clinical Oncology|November 1, 2022
Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasisChi-Lu Chiang, Hsiang-Ling Ho, Yi-Chen Yeh, et al.
Plos One|April 28, 2022
Efficacy of liquid biopsy for disease monitoring and early prediction of tumor progression in EGFR mutation-positive non-small cell lung cancerHsiang-Ling Ho, Yuqiu Jiang, Chi-Lu Chiang, et al.
Thoracic Cancer|March 28, 2023
Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell-free DNA from non-small-cell lung cancer patients with leptomeningeal metastasesChi-Lu Chiang, Hsiang-Ling Ho, Yi-Chen Yeh, et al.
Alimentary Pharmacology & Therapeutics|November 25, 2024
Hepatic Events During Immune Checkpoint Inhibitor Treatment Between Liver and Non-Liver Malignancies in Hepatitis B Endemic AreasYi-Ping Hung, Pei-Chang Lee, Yen-Hwa Chang, et al.
Targeted Oncology|June 17, 2023
Efficacy and Tolerability of Ramucirumab Plus Erlotinib in Taiwanese Patients with Untreated, Epidermal Growth Factor Receptor-Mutated, Stage IV Non-small Cell Lung Cancer in the RELAY StudyChao-Hua Chiu, Meng-Chih Lin, Yu-Feng Wei, et al.
Pageof 10